Cargando…
Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD
BACKGROUND: Previous research has demonstrated that epigenetic changes in specific hypothalamic-pituitary-adrenal (HPA) genes may predict successful psychotherapy in post-traumatic stress disorder (PTSD). A recent Phase 3 clinical trial reported high efficacy of 3,4-methylenedioxymethamphetamine (MD...
Autores principales: | Lewis, Candace R., Tafur, Joseph, Spencer, Sophie, Green, Joseph M., Harrison, Charlotte, Kelmendi, Benjamin, Rabin, David M., Yehuda, Rachel, Yazar-Klosinski, Berra, Cahn, Baruch Rael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939628/ https://www.ncbi.nlm.nih.gov/pubmed/36815187 http://dx.doi.org/10.3389/fpsyt.2023.959590 |
Ejemplares similares
-
The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020) -
Psychotherapy-supported MDMA treatment for PTSD
por: Krystal, John H., et al.
Publicado: (2021) -
Fully Validated, Multi-Kilogram cGMP Synthesis of
MDMA
por: Nair, Jay B., et al.
Publicado: (2021) -
Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017) -
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
por: Jerome, Lisa, et al.
Publicado: (2020)